Right. The 1.0-log reduction was in HBV RNA relative to baseline.
The reduction in HBV DNA relative to baseline is not a meaningful number in nuke-suppressed patients, who have undetectable HBV DNA (or an extremely low detectable level) while continuing nuke treatment.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”